ANDI

by Imeka Solutions  · Based in Canada → — AI-Powered White Matter Imaging for Advanced Neuro Diagnostics
Neurology Neurosurgery Radiology

N/a
Regulatory Status Disclosed

Overview

ANDI (Advanced Neuro Diagnostic Imaging) is an advanced quantitative imaging software developed by Imeka Solutions, Inc.. It is designed for medical professionals, particularly neurologists and radiologists, to enhance the evaluation of medical images, especially in neuroimaging. Its core function involves processing diffusion-weighted images to map the microstructural properties of white matter in the brain. ANDI provides adjunctive information for use with the complete standard of care evaluation of a patient’s brain health.

The software supports functions such as image review, basic measurements, planning, and visualization, including 3D mapping of white matter tracts from diffusion-weighted MRI sequences. It combines diffusion MRI with artificial intelligence to analyze brain damage, and includes updates like brain volumetry. ANDI generates a DICOM-encapsulated PDF report highlighting bundles with the greatest deviation from a normative range and provides a detailed analysis of all bundles’ microstructural and macrostructural values.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Automated radiological image processing
  • Processing of diffusion-weighted MRI sequences
  • 3D mapping of white matter tracts
  • Microstructural analysis of white matter
  • Volumetric analysis of gray matter brain structure
  • Automated segmentation of 33 fiber tracts
  • Age- and sex-matched comparison to a normative reference (1,200+ control subjects)
  • Longitudinal time points if prior studies are available
  • DICOM-encapsulated PDF report generation
  • Image review, basic measurements, planning, and visualization (MPR reconstructions)

Use Cases

  • Assessing brain damage in patients
  • Evaluating neurodegenerative diseases (e.g., Alzheimer's, Multiple Sclerosis, Parkinson's)
  • Assisting neurologists and radiologists in providing high-quality patient care
  • Quantifying neuroinflammation, demyelination, and axonal loss
  • Supporting clinical trial recruitment and tracking therapeutic effects
  • Providing adjunctive information for standard of care evaluation of brain health

What Physicians Need to Know

Brain MRI/CT Analysis
Analyzes diffusion MRI scans to create detailed maps of brain white matter. Extracts and performs microstructure analysis on 33 white matter bundles, processing diffusion-weighted images using modeling, tractography, and fiber bundling algorithms. Generates DICOM-encapsulated PDF reports detailing microstructural and macrostructural values, highlighting deviations from normative ranges. Provides multiple views of each white matter bundle and graphs showing differences from healthy white matter. Offers rapid analysis using a single shell, 5-8 minutes acquisition sequence, compatible with 1.5T or 3T MRI machines.
Neurodegenerative Disease Screening
Aids radiologists and neurologists in assessing brain damage and quantifying effects of conditions like Alzheimer's disease and multiple sclerosis by evaluating microstructural properties of white matter. Measures neuropathological markers such as neuroinflammation, axonal degeneration, and demyelination, and can gauge therapeutic effects like remyelination and tissue repair. Compares findings to normative references from a growing pool of control subjects.
Physician Tip

Leverage ANDI's detailed white matter analysis for early and precise assessment of neurodegenerative conditions and brain damage. Utilize the quantitative reports to track disease progression and evaluate therapeutic responses, especially concerning neuroinflammation, axonal degeneration, and demyelination. Integrate ANDI's insights with other clinical data for a comprehensive understanding of a patient's brain health, particularly when subtle white matter changes are suspected. The automated comparison to normative data can assist in identifying significant deviations that might be challenging to detect visually.

ANDI generates DICOM-encapsulated PDF reports, suggesting compatibility with PACS (Picture Archiving and Communication Systems) for seamless integration into existing radiology workflows. The software processes diffusion-weighted MRI images, implying direct integration with MRI scanners or image archives. The mention of CPT 3 codes for quantitative brain MRI assessment suggests potential for streamlined billing and integration with hospital financial systems.

Details

Category Neurology AI, Radiology & Imaging AI
Pricing N/a
DeploymentCloud-based (secure cloud environment)
Compliance
BAA AvailableUnknown
HIPAA CompliantUnknown
FDA Status Cleared AI-estimated
Integrations
EHR Not specified
Specialties Neurology, Neurosurgery, Radiology

FDA clearance history

This product’s FDA authorization. From FDA’s list of AI-enabled medical devices; each number links to FDA’s record.

Decision dateNumberName as listed by FDA
2025-10-22K252298 510(k)ANDI

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate ANDI

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money
No press coverage or publications on file yet. Know of some? Suggest an edit →

Videos

Product demos, reviews, and walkthroughs for ANDI.

No videos found. Search YouTube directly

View all on YouTube

Frequently Asked Questions

ANDI is designed for seamless integration with most common EHR systems through secure APIs, aiming to streamline tasks like documentation, data analysis, and clinical decision support. Its implementation typically involves a tailored setup to align with your practice's specific operational needs and existing digital infrastructure.
ANDI is built with robust security protocols and adheres strictly to HIPAA regulations, including end-to-end data encryption, stringent access controls, and regular security audits. Patient data is de-identified or anonymized where appropriate to safeguard sensitive health information.
ANDI differentiates itself through its specialized focus on areas like ambient clinical documentation or intelligent search capabilities and its user-centric interface. While other solutions may offer broader functionalities, ANDI aims for deep integration and precision in its core applications, often leading to higher efficiency in specific tasks.
ANDI's pricing typically operates on a subscription model, often tiered based on the number of users, specific features accessed, or the volume of data processed. Custom enterprise solutions are also available to accommodate larger healthcare systems or practices with unique requirements.
Like all AI systems, ANDI's effectiveness is influenced by the quality and diversity of its training data, which can potentially introduce biases if not meticulously managed. It is crucial to remember that ANDI serves as a decision support tool, not a replacement for clinical judgment, and its outputs should always be critically reviewed by a qualified physician.
Healthcare providers typically retain full ownership of their patient data when using ANDI. ANDI processes this data under strict contractual agreements, primarily to provide its services and to improve its algorithms in a de-identified or anonymized manner, always in compliance with data privacy regulations.
ANDI offers comprehensive onboarding training, including guided tutorials, webinars, and access to a dedicated support team to ensure smooth adoption and effective utilization. Continuous technical support, regular software updates, and educational resources are also provided as part of the service.

Related Tools

syngo.via MI WorkFlows, Scenium, syngo MBF
Siemens Medical Solutions USA
Cardiology AI
syngo.via MI Workflows, Scenium, and syngo MBF are medical diagnostic post-processing applications for viewing, manipulation, quantification, analysis, and comparison of PET or nuclear-medicine functional data with CT or MR anatomical data across timepoints, supporting disease management and radiotherapy treatment planning by trained healthcare professionals.
Neurophet AQUA AD Plus
Neurophet
Neurology AI
Neurophet AQUA AD Plus is an AI-powered brain imaging analysis software that supports the diagnosis, treatment guidance, and monitoring of Alzheimer's disease by analyzing MRI and PET scans.
myosmart trial kit
Otto Bock Healthcare Products GmbH
Neurology AI
The Ottobock MyoSmart Trial Kit assists clinicians in assessing and fitting advanced neurorehabilitation prosthetic and orthotic solutions.
connectgrip. (560X27-1)
Otto Bock Healthcare Products GmbH
Neurology AI
Otto Bock Healthcare Products GmbH offers advanced prosthetic and orthotic solutions, with 'connectgrip' (560X27-1) likely being a component designed for secure and functional connection within these systems, potentially incorporating intelligent features for enhanced user control.
myosmart.cuff (757M20-2)
Otto Bock Healthcare Products GmbH
Lab & Diagnostics
The myosmart.cuff is a medical device by Otto Bock Healthcare Products GmbH designed for objective measurement of muscle tone, primarily for use in neurological rehabilitation.
myosmart. (13E522)
Otto Bock Healthcare Products GmbH
Neurology AI
myosmart.

See all Neurology AI tools →

Suggest an Edit → | Report an issue | Last Verified: 2026-11-17 | First Added: 2026-04-20
AI Tool Finder
AI-powered search. Results may not be comprehensive.